Understanding Radiobiological Drivers Beyond Absorbed Dose to Strengthen RLT Candidate Selection

11:30 am - Thursday 25th February 2027

  • Interrogate cellular uptake and target-specific biology to understand how biological characteristics influence therapeutic response beyond absorbed dose alone
  • Leverage knockout and knock-in models alongside in vitro and in vivo validation to establish target-specific effects and strengthen confidence in the underlying biology
  • Integrate imaging and therapy studies throughout preclinical development to connect biological response with candidate performance and inform progression towards the clinic

Speakers:

Co-Founder & Head of Biology
Nuclide Therapeutics